| Title | Recent Advances in Anti-Infective Drug Discovery |
| Abbreviation | Recent Adv. Anti-Infect. Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3) |
| h-index | 35 |
| Overall Rank/Ranking | 15938 |
| SCImago Journal Rank (SJR) | 0.277 |
| Impact Score | 1.30 |
| Publisher | Bentham Science Publishers |
| Country | United Arab Emirates |
| ISSN | 27724352, 27724344 |
| Best Quartile | Q3 |
| Coverage History | 2021-2022 |
Recent Advances in Anti-Infective Drug Discovery is a journal covering the technologies/fields/categories related to Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3). It is published by Bentham Science Publishers. The overall rank of Recent Advances in Anti-Infective Drug Discovery is 15938. According to SCImago Journal Rank (SJR), this journal is ranked 0.277. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 35. The best quartile for this journal is Q3.
The ISSN of Recent Advances in Anti-Infective Drug Discovery journal is 27724352, 27724344. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Recent Advances in Anti-Infective Drug Discovery is cited by a total of 82 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Recent Advances in Anti-Infective Drug Discovery is 1.30, which is computed in 2023 as per its definition. Recent Advances in Anti-Infective Drug Discovery IF is decreased by a factor of 0.1 and approximate percentage change is -7.14% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Recent Advances in Anti-Infective Drug Discovery is 1.30. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.30 |
| 2021 | 1.40 |
| 2020 | 1.88 |
| 2019 | 0.97 |
| 2018 | 0.96 |
| 2017 | 1.26 |
| 2016 | 1.25 |
| 2015 | 2.15 |
| 2014 | 2.00 |
Recent Advances in Anti-Infective Drug Discovery has an h-index of 35. It means 35 articles of this journal have more than 35 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Recent Advances in Anti-Infective Drug Discovery is 27724352, 27724344. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Recent Advances in Anti-Infective Drug Discovery is 15938. According to SCImago Journal Rank (SJR), this journal is ranked 0.277. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.277 |
| 2021 | 0.301 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 15938 |
| 2021 | 14762 |
| 2020 | 34528 |
| 2019 | 32259 |
| 2018 | 33748 |
| 2017 | 34513 |
| 2016 | 33962 |
| 2015 | 33449 |
| 2014 | 32724 |
Recent Advances in Anti-Infective Drug Discovery is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2021-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Recent Advances in Anti-Infective Drug Discovery is Recent Adv. Anti-Infect. Drug Discov.. This abbreviation ('Recent Adv. Anti-Infect. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (medical) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Recent Advances in Anti-Infective Drug Discovery latest impact IF is 1.30. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.15 (2015) and 0.96 (2018), respectively, in the last 9 years. Moreover, its average IS is 1.46 in the previous 9 years.
The Recent Advances in Anti-Infective Drug Discovery has an SJR (SCImago Journal Rank) of 0.277, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.301 in 2021 and the lowest being in 2020. Furthermore, the average SJR of the Recent Advances in Anti-Infective Drug Discovery over the previous 9-year period stands at 1.46.
The latest h-index of the Recent Advances in Anti-Infective Drug Discovery is 35.
The Recent Advances in Anti-Infective Drug Discovery is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.
The Recent Advances in Anti-Infective Drug Discovery is currently ranked 15938 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 14762 in 2021 and its lowest position of 34528 in 2020.
The standard ISO4 abbreviation for the Recent Advances in Anti-Infective Drug Discovery is Recent Adv. Anti-Infect. Drug Discov..
Recent Advances in Anti-Infective Drug Discovery is classified as a journal that the Bentham Science Publishers publishes.
The Recent Advances in Anti-Infective Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Recent Advances in Anti-Infective Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 27724352, 27724344.
The best quartile for the Recent Advances in Anti-Infective Drug Discovery is Q3 (2022).
The Recent Advances in Anti-Infective Drug Discovery coverage history can be summarized as follows: 2021-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| Journal of Field Archaeology | journal | 5639 | Maney Publishing | 43 | 2.38 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Qualitative Research | journal | 2108 | SAGE Publications Ltd | 86 | 3.97 |
| Criminal Justice Review | journal | 8738 | SAGE Publications Inc. | 41 | 1.30 |
| Journal of Supply Chain Management | journal | 378 | Wiley-Blackwell | 104 | 12.58 |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
| Natural Solutions | trade journal | 28581 | Innovision Health Media | 1 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.30 |
| 2021 | 1.40 |
| 2020 | 1.88 |
| 2019 | 0.97 |
| 2018 | 0.96 |
| 2017 | 1.26 |
| 2016 | 1.25 |
| 2015 | 2.15 |
| 2014 | 2.00 |
